Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) — Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today announced